Skip to main content
SpringerLink
Log in

Determination of IGHV gene mutational status in chronic lymphocytic leukemia: bioinformatics advances meet clinical needs

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stilgenbauer S, Stevenson F et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 2007; 21: 1–3.

    Article  CAS  Google Scholar 

  2. http://vbase.mrc-cpe.cam.ac.uk (last accessed August 2007).

  3. http://www.ncbi.nlm.nih.gov/igblast (last accessed August 2007).

  4. Lefranc M-P, Giudicelli V, Kaas Q, Duprat E, Jabado-Michaloud J, Scaviner D et al. IMGT, the international ImMunoGeneTics information system®. Nucleic Acids Res 2005; 33: D593–D597.

    Article  CAS  Google Scholar 

  5. Lane BS, Mensah AA, Lin K, Pettitt AR, Sherrington PD . Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance. Leukemia 2005; 19: 741–749.

    Article  CAS  Google Scholar 

  6. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105: 1678–1685.

    Article  CAS  Google Scholar 

  7. Pekova S, Baran-Marszak F, Schwarz J, Matoska V . Mutated or non-mutated? Which database to choose when determining the IgVH hypermutation status in chronic lymphocytic leukemia? Haematologica 2006; 91: ELT01.

    Google Scholar 

  8. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Hematology and University Pierre et Marie Curie, Hôpital Pitié-Salpètrière, Paris, France

    F Davi

  2. Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden

    R Rosenquist

  3. Department of Oncology, Università Vita-Salute San Raffaele e Istituto Scientifico San Raffaele, Milano, Italy

    P Ghia

  4. Department of Hematology, Nikea General Hospital, Athens, Greece

    C Belessi

  5. Department and HCT Unit, Hematology, G Papanicolaou Hospital, Thessaloniki, Greece

    K Stamatopoulos

Authors
  1. F Davi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Rosenquist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Ghia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Belessi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Stamatopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Davi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davi, F., Rosenquist, R., Ghia, P. et al. Determination of IGHV gene mutational status in chronic lymphocytic leukemia: bioinformatics advances meet clinical needs. Leukemia 22, 212–214 (2008). https://doi.org/10.1038/sj.leu.2404969

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404969

  • Springer Nature Limited

This article is cited by

Search

Navigation